Display options
Share it on

Evid Based Complement Alternat Med. 2016;2016:2052180. doi: 10.1155/2016/2052180. Epub 2016 Apr 27.

Antioxidant and Anti-Inflammatory Effects of Rhei Rhizoma and Coptidis Rhizoma Mixture on Reflux Esophagitis in Rats.

Evidence-based complementary and alternative medicine : eCAM

O Jun Kwon, Min Yeong Kim, Sung Ho Shin, Ah Reum Lee, Joo Young Lee, Bu-Il Seo, Mi-Rae Shin, Hyun Gyu Choi, Jeong Ah Kim, Byung Sun Min, Gyo-Nam Kim, Jeong Sook Noh, Man Hee Rhee, Seong-Soo Roh

Affiliations

  1. Kyeoungbuk Institute for Regional Program Evaluation, Gyeongbuk TP, 27 Sampoong-ro, Gyeongsan, Gyeongsangbuk-do 38542, Republic of Korea.
  2. College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.
  3. College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
  4. College of Pharmacy, Catholic University of Daegu, Gyeongsangbuk-do 38430, Republic of Korea.
  5. Department of Food Science and Biotechnology, Kyungnam University, Gyeongsangnam-do 51767, Republic of Korea.
  6. Department of Food Science & Nutrition, Tongmyong University, Busan 48520, Republic of Korea.
  7. College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.

PMID: 27239206 PMCID: PMC4863117 DOI: 10.1155/2016/2052180

Abstract

The purpose of this study was to investigate the antioxidant and anti-inflammatory effects of the combined extract of Rhei rhizoma and Coptidis rhizoma (RC-mix) in experimental model of acute reflux esophagitis. The antioxidant activity was assessed by in vitro 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays. RC-mix was given at 100, 200, and 400 mg/kg body weight 2 h prior to induction of reflux esophagitis (RE). After 5 h, the effects of RC-mix treated rats were compared with those of normal and control rats. The representative flavonoid contents of RC-mix, such as sennoside A, epiberberine, coptisine, palmatine, and berberine, were detected using HPLC. The elevated esophageal mucosa damage was markedly ameliorated by RC-mix treatment in a dose-dependent manner. Furthermore, the administration of RC-mix reduced the increase of serum reactive oxygen species (ROS) and peroxynitrite (ONOO(-)). The improvement of superoxide dismutase (SOD) and heme oxygenase-1 (HO-1) levels were marked in the group given RC-mix. Moreover, the elevation of inflammatory mediators and cytokines by nuclear factor-kappa B (NF-κB) activation in control rats decreased by RC-mix pretreatment. These results indicate that RC-mix treatment reduces the pathological states of esophagitis via regulating NF-κB mediated inflammation related to oxidative stress.

References

  1. Ann N Y Acad Sci. 2008 Dec;1147:61-9 - PubMed
  2. Carcinogenesis. 2012 Nov;33(11):2035-43 - PubMed
  3. Am J Chin Med. 2014;42(5):1053-70 - PubMed
  4. J Physiol Pharmacol. 2014 Dec;65(6):809-22 - PubMed
  5. Int J Mol Sci. 2013 Nov 13;14(11):22274-330 - PubMed
  6. Curr Opin Pharmacol. 2004 Aug;4(4):386-91 - PubMed
  7. Neurotoxicology. 1992 Fall;13(3):637-48 - PubMed
  8. Minerva Gastroenterol Dietol. 2009 Sep;55(3):289-300 - PubMed
  9. Free Radic Biol Med. 1999 May;26(9-10):1231-7 - PubMed
  10. Evid Based Complement Alternat Med. 2015;2015:361847 - PubMed
  11. Anal Chim Acta. 2012 Aug 6;737:99-104 - PubMed
  12. Toxicol Res. 2014 Mar;30(1):45-8 - PubMed
  13. Evid Based Complement Alternat Med. 2014;2014:510157 - PubMed
  14. Biomol Ther (Seoul). 2014 Sep;22(5):420-5 - PubMed
  15. Exp Ther Med. 2013 Sep;6(3):663-670 - PubMed
  16. Pharm Biol. 2015 Jul;53(7):1022-9 - PubMed
  17. Med Res Rev. 2007 Sep;27(5):609-30 - PubMed
  18. Indian J Med Res. 2012 Mar;135:407-13 - PubMed
  19. Gut. 2001 Sep;49(3):364-71 - PubMed
  20. J Gastroenterol. 2003 Mar;38 Suppl 15:31-4 - PubMed
  21. J Neurogastroenterol Motil. 2011 Jan;17(1):14-27 - PubMed
  22. Oxid Med Cell Longev. 2015;2015:703709 - PubMed
  23. Surg Innov. 2005 Sep;12(3):219-25 - PubMed
  24. Fitoterapia. 2012 Sep;83(6):1014-22 - PubMed
  25. World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):105-12 - PubMed
  26. Free Radic Biol Med. 2001 Apr 15;30(8):905-15 - PubMed
  27. Mutat Res. 2001 Sep 1;480-481:189-200 - PubMed
  28. Evid Based Complement Alternat Med. 2014;2014:289264 - PubMed
  29. J Natl Cancer Inst. 2002 Mar 20;94(6):422-9 - PubMed
  30. Ann Surg. 2004 Apr;239(4):491-500 - PubMed
  31. BMC Complement Altern Med. 2015 Feb 27;15:35 - PubMed
  32. World J Gastroenterol. 2013 Oct 21;19(39):6523-8 - PubMed
  33. Gut. 2005 May;54(5):710-7 - PubMed
  34. J Gastroenterol Hepatol. 2012 Jun;27(6):1004-10 - PubMed
  35. Tissue Barriers. 2013 Dec 1;1(5):e27463 - PubMed
  36. Evid Based Complement Alternat Med. 2015;2015:187265 - PubMed
  37. Int J Biochem Cell Biol. 2010 Apr;42(4):519-23 - PubMed
  38. Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943 - PubMed
  39. Biomed Res Int. 2014;2014:532594 - PubMed
  40. Methods Mol Biol. 2007;355:73-7 - PubMed
  41. Korean J Physiol Pharmacol. 2013 Feb;17(1):81-7 - PubMed
  42. Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1131-9 - PubMed
  43. Prev Nutr Food Sci. 2015 Mar;20(1):22-8 - PubMed
  44. Cell Mol Life Sci. 2015 Mar;72 (6):1161-73 - PubMed
  45. J Ethnopharmacol. 2011 Jun 1;135(3):754-61 - PubMed
  46. Scand J Gastroenterol. 1999 Oct;34(10):948-53 - PubMed
  47. Free Radic Biol Med. 1994 Feb;16(2):149-56 - PubMed
  48. J Clin Biochem Nutr. 2007 Jan;40(1):13-23 - PubMed
  49. Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G571-81 - PubMed
  50. Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):3-8 - PubMed
  51. Mol Med Rep. 2012 May;5(5):1261-6 - PubMed

Publication Types